Two advertisements in a medical journal for the painkiller OxyContin failed to properly warn about the drug’s safety risks and potential for abuse, US regulators said in a letter released on Wednesday.
The ads, which appeared last fall in the Journal of the American Medical Association, also suggested broader use of the prescription drug than what is approved, the US Food and Drug Administration said in a warning letter.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!